Back to search

University of British Columbia

Development of engineered heart tissues with sacrificial alginate-fibrinogen bioink using low-cost open-source 3D bioprinter

Abstract

dc:description

Introduction: As cardiovascular disease becomes more prevalent in aging society and continues to be one of the leading causes of death globally, early intervention is required to prevent disease onset and progression. Intervention can be accomplished by characterizing disease physiology, mechanism, and biomarkers to screen and develop efficient personalized therapies. Recent technological advances such as the development of 3-dimensional engineered heart tissue models and optical mapping can allow for the study of certain diseases for drug screening. However, the model can be prone to batch-to-batch variation, immature contractile force and inconsistent electrophysiology compared to the adult heart. Objective: The aim of this proposed study is to develop a low-cost open-source 3D bioprinter to fabricate reproducible and physiologically accurate heart tissues. Method: A desktop 3D printer was converted into a bioprinter by replacing the thermal extrusion nozzle with custom syringe pumps. The print fidelity was characterized using alginate ink and gelatin support bath. Functional tissues were printed using induced pluripotent stem cells differentiated cardiomyocytes (iPSC-CM) embedded in bioink containing sacrificial alginate and fibrinogen. Contractile output, electrophysiology, and sarcomere alignment of printed tissues was compared with manually casted tissues. Results: The custom 3D bioprinter showed high accuracy and precision of ±40um and ±4um for all axes. Printed filaments exhibited high uniformity across different printing parameters, while the diameter was primarily affected by the flowrate modifier and nozzle size, linearly. Cell-laden prints preserved high cell viability of >90% for over 2 weeks. Cell-laden printed tissues were compacted by dissolving alginate with EDTA induced spontaneous contraction and produced lower variation in normalized contractile force compared to manually casted tissues. Although printed tissues were found to have a longer APD80 under varying cycle length than manually casted tissues, both printed and manually casted tissues were shown to have similar action potential triangulation as ventricular cells with an APD30/APD80 of 0.70. Lastly, although printed tissues had a lower sarcomere alignment, exploratory findings suggested that printed tissues may influence intercellular structures. Overall, we have shown that our bioprinter is feasible in fabricating high-throughput and reproducible cardiac tissues for future drug and disease screening.

Degree

thesis:*
Name thesis:degree_name
Master of Applied Science - MASc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor dc:publisher
University of British Columbia
Year dc:date
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Sacayanan, Ardin
Contributors dc:contributor
  • Laksman, Zachary

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/94772

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Sacayanan, Ardin. Development of engineered heart tissues with sacrificial alginate-fibrinogen bioink using low-cost open-source 3D bioprinter. master's thesis, University of British Columbia, 2026. http://hdl.handle.net/2429/94772